Gyre Therapeutics Inc. (GYRE) — Financial Flexibility Index
Gyre Therapeutics Inc. (GYRE) has a Financial Flexibility Index of 0.24x as of September 2025. Free cash flow of $5.36 Million (operating CF $4.68 Million minus capex $683.00K) represents 0% of total liabilities ($21.97 Million). Also explore net asset growth rate of Gyre Therapeutics Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gyre Therapeutics Inc. Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for Gyre Therapeutics Inc. across 21 annual periods. Check Gyre Therapeutics Inc. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Gyre Therapeutics Inc. (2004–2024)
Year-by-year free cash flow to debt coverage for Gyre Therapeutics Inc.. For the full company profile including market capitalisation, see how much is Gyre Therapeutics Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | $-513.00K | $-3.64 Million | $27.00 Million | ▼ -105.7% |
| 2023 | 0.34x | $34.48 Million | $25.89 Million | $102.59 Million | ▼ -73.1% |
| 2022 | 1.25x | $15.68 Million | $10.68 Million | $12.54 Million | ▲ +122.0% |
| 2021 | -5.69x | $-82.92 Million | $-83.75 Million | $14.57 Million | ▼ -95.0% |
| 2020 | -2.92x | $-54.78 Million | $-55.05 Million | $18.78 Million | ▼ -102.4% |
| 2019 | -1.44x | $-43.55 Million | $-43.61 Million | $30.22 Million | ▲ +74.6% |
| 2018 | -5.66x | $-28.18 Million | $-28.55 Million | $4.97 Million | ▼ -148.5% |
| 2017 | -2.28x | $-19.92 Million | $-19.94 Million | $8.74 Million | ▼ -178.7% |
| 2016 | -0.82x | $-18.00 Million | $-18.47 Million | $22.02 Million | ▼ -65.3% |
| 2015 | -0.49x | $-18.85 Million | $-19.12 Million | $38.10 Million | ▲ +95.8% |
| 2014 | -11.83x | $-34.48 Million | $-34.48 Million | $2.91 Million | ▼ -228.9% |
| 2013 | -3.60x | $-40.52 Million | $-40.61 Million | $11.26 Million | ▲ +23.1% |
| 2012 | -4.68x | $-63.91 Million | $-64.24 Million | $13.66 Million | ▼ -376.5% |
| 2011 | -0.98x | $-82.29 Million | $-83.72 Million | $83.84 Million | ▼ -218.5% |
| 2010 | 0.83x | $141.61 Million | $138.30 Million | $170.94 Million | ▲ +961.7% |
| 2009 | -0.10x | $-24.07 Million | $-24.27 Million | $250.39 Million | ▲ +84.9% |
| 2008 | -0.64x | $-26.21 Million | $-28.26 Million | $41.18 Million | ▼ -201.3% |
| 2007 | 0.63x | $29.78 Million | $24.84 Million | $47.38 Million | ▲ +216.7% |
| 2006 | -0.54x | $-8.82 Million | $-9.89 Million | $16.37 Million | ▼ -294.6% |
| 2005 | -0.14x | $-26.00 Million | $-26.25 Million | $190.48 Million | ▼ -1.4% |
| 2004 | -0.13x | $-24.38 Million | $-25.04 Million | $181.17 Million | — |